Multicomponent Plasmid Protects Mice From Spontaneous Autoimmune Diabetes.

Pagni, Philippe P; Chaplin, Jay; Wijaranakula, Michael; Wesley, Johnna D; Granger, Jaimie; Cracraft, Justen; O'Brien, Conor; Perdue, Nikole; Kumar, Vijetha; Li, Shangjin; Ratliff, Sowbarnika Sachithanantham; Roach, Allie; Misquith, Ayesha; Chan, Chung-Leung; Coppieters, Ken; von Herrath, Matthias

Pagni, Philippe P; Chaplin, Jay; Wijaranakula, Michael; Wesley, Johnna D; Granger, Jaimie; Cracraft, Justen; O'Brien, Conor; Perdue, Nikole; Kumar, Vijetha; Li, Shangjin; Ratliff, Sowbarnika Sachithanantham; Roach, Allie; Misquith, Ayesha; Chan, Chung-Leung; Coppieters, Ken; von Herrath, Matthias.

Afiliação

Pagni PP; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.
Chaplin J; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.
Wijaranakula M; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.
Wesley JD; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.
Granger J; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.
Cracraft J; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.
O'Brien C; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.
Perdue N; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.
Kumar V; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.
Li S; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.
Ratliff SS; La Jolla Institute for Immunology, La Jolla, CA, USA.
Roach A; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.
Misquith A; Discovery Biologics, Global Research Technologies, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.
Chan CL; Discovery Biologics, Global Research Technologies, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.
Coppieters K; Project and Alliance Management, Global Drug Discovery, Novo Nordisk A/S, Måløv, Denmark.
von Herrath M; La Jolla Institute for Immunology, La Jolla, CA, USA.

Diabetes ; 2021 Aug 13.

Article em En | MEDLINE | ID: mdl-34957480

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Diabetes Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google